Calyxt, Inc. (CLXT) Stock

About Calyxt, Inc.

Calyxt, Inc. is a synthetic biology firm that engineers plant-based solutions, primarily serving the agricultural industry in the United States. The company innovates in areas such as developing easily digestible alfalfa, cultivating hemp, and producing wheat varieties with elevated fiber content. They hold an exclusive commercialization pact with S&W Seed Company to license their superior alfalfa seed across both U.S. and international markets. Established in 2010 and headquartered in Roseville, Minnesota, the entity operated as Cellectis Plant Sciences, Inc. before adopting the name Calyxt, Inc. in May 2015. Calyxt, Inc. functions as a subsidiary of Cellectis S.A.

Calyxt, Inc. is headquartered in US.

Calyxt, Inc. (CLXT) stock trades at $6.30 with a market capitalization of $31.33M. The stock is valued at a negative price-to-earnings (P/E) ratio of -3.20, reflecting a net loss over the last twelve months, price-to-book of 115.78, price-to-sales of 7.31. Over the past 52 weeks the stock has ranged between $6.01 and $38.85, and currently trades 83.8% below its 52-week high.

On profitability, Calyxt, Inc. generates a return on equity (ROE) of -227.28% (negative, reflecting a net loss), return on capital employed of -21.94%, an operating margin of -2450.00%, a net profit margin of -3175.00%.

Official website: calyxt.com